The role of hypofractionated radiotherapy for the definitive treatment of localized prostate cancer: early results of a randomized trial
Conclusions: Hypofractionated radiotherapy appears to be equally tolerated compared to conventional fractionation in the early setting. Longer follow up is needed to assess the late toxicity profile of the patients and any potential differences between the control and experimental arm.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Petros Alexidis, Dimitris Dragoumis, Sotirios Karatzoglou, Konstantinos Drevelegas, Ioannis Tzitzikas, Konstantinos Hatzimouratidis, Ioannis Chrisogonidis, Dimitris Giannakidis, Charilaos Koulouris, Athanasios Katsaounis, Nikolaos Michalopoulos, Haidong H Tags: Research Paper Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Gastroenterology | Hormonal Therapy | Hormones | Prostate Cancer | Radiation Therapy | Statistics | Study | Toxicology